The trial data provided clinical evidence indicating that LAAC with the WATCHMAN FLX device is safe and superior to oral anticoagulation (OAC) therapy for reducing the risk of long-term bleeding ...
They randomly assigned 803 patients to left atrial appendage closure with the Watchman FLX device and 797 patients to oral anticoagulation therapy from November 2019 through June 2021. Mean ...